Inequalities in breast cancer care and outcome.

Comparisons across Europe suggest that survival from breast cancer is less good in the United Kingdom than in many countries. The care given in some UK breast cancer units is exemplary. However, it is difficult to escape the conclusion that a substantial number of women who present with breast cancer receive suboptimal care. Cancer registry-based studies have clearly demonstrated variations between surgeons and between hospitals in the management of early breast cancer. Although variations in surgical practice per se may have little impact on survival, there is evidence that differences in the use of systemic adjuvant therapy influence outcome. Five-year survival seems to be greater in women treated by surgeons seeing more than 30-50 new cases of breast cancer each year. This may be because such patients are more likely to be treated by a multidisciplinary team and to receive adjuvant therapy. Proposals that would increase the overall quality of breast cancer care and remove current inequalities must be carefully considered and should then be implemented.

[1]  A. Cameron,et al.  Delay in seeking treatment for mammary tumors , 1968, Cancer.

[2]  C. MacArthur,et al.  DELAY IN BREAST CANCER AND THE NATURE OF PRESENTING SYMPTOMS , 1981, The Lancet.

[3]  W. Waters,et al.  Delay in the presentation of breast symptoms for consultant investigation. , 1981, Community medicine.

[4]  M. Saunders,et al.  The effects of patient delay and symptoms other than a lump on survival in breast cancer , 1983, Cancer.

[5]  Consensus development conference: treatment of primary breast cancer. , 1986, British medical journal.

[6]  Reducing diagnostic delay in breast cancer possible therapeutic implications , 1986, Cancer.

[7]  A. Crucitti,et al.  Diagnostic Delay in Breast Cancer: Correlation with Disease Stage and Prognosis , 1990, Tumori.

[8]  W. Gregory,et al.  Advanced breast cancer: use of resources and cost implications. , 1993, British Journal of Cancer.

[9]  R. K. Knight,et al.  Chemotherapy of advanced breast cancer: outcome and prognostic factors. , 1993, British Journal of Cancer.

[10]  A. M. Chouuillett,et al.  Management of breast cancer in southeast England , 1994, BMJ.

[11]  R. Doll,et al.  Trends in cancer incidence and mortality , 1994 .

[12]  A. Catterall Guidelines for surgeons in the management of symptomatic breast disease in the United Kingdom. , 1996, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[13]  M. Coleman,et al.  Deprivation and survival from breast cancer. , 1995, British Journal of Cancer.

[14]  C. Round,et al.  Influence of clinician workload and patterns of treatment on survival from breast cancer , 1995, The Lancet.

[15]  R. Sainsbury,et al.  Does it matter where you live? Treatment variation for breast cancer in Yorkshire. The Yorkshire Breast Cancer Group. , 1995, British Journal of Cancer.

[16]  J. Estève [Changes in the incidence and mortality of breast cancer in England and Wales since the introduction of screening]. , 1996, Revue d'epidemiologie et de sante publique.

[17]  C. Gillis,et al.  Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland , 1996, BMJ.

[18]  C. Wolfe,et al.  Variations in the management and survival of women under 50 years with breast cancer in the South East Thames region. , 1996, British Journal of Cancer.